Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1981 1
1986 1
1987 2
1989 2
1990 1
1991 3
1992 1
1993 2
1994 3
1995 2
1996 8
1997 6
1998 12
1999 6
2000 5
2001 6
2002 3
2003 4
2004 10
2005 12
2006 9
2007 13
2008 18
2009 16
2010 7
2011 20
2012 3
2013 9
2014 5
2015 6
2016 4
2017 9
2018 5
2019 6
2020 11
2021 9
2022 6
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

242 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Indications for Growth Hormone Therapy.
Danowitz M, Grimberg A. Danowitz M, et al. Adv Pediatr. 2022 Aug;69(1):203-217. doi: 10.1016/j.yapd.2022.03.005. Epub 2022 Jun 17. Adv Pediatr. 2022. PMID: 35985710 Free PMC article. Review.
In the United States, there are 8 Food and Drug Administration (FDA)-approved indications for pediatric GH therapy: GH deficiency, Prader-Willi Syndrome, small for gestational age (SGA) without catch-up growth, idiopathic short stature, Turner syndrome, SHOX …
In the United States, there are 8 Food and Drug Administration (FDA)-approved indications for pediatric GH therapy: GH deficiency, Prader-Wi …
Growth hormone treatment for growth hormone deficiency and idiopathic short stature: new guidelines shaped by the presence and absence of evidence.
Grimberg A, Allen DB. Grimberg A, et al. Curr Opin Pediatr. 2017 Aug;29(4):466-471. doi: 10.1097/MOP.0000000000000505. Curr Opin Pediatr. 2017. PMID: 28525404 Free PMC article. Review.
PURPOSE OF REVIEW: The Pediatric Endocrine Society recently published new guidelines for the use of human growth hormone (hGH) and human insulin-like growth factor-I (hIGF-I) treatment for growth hormone deficiency, idiopathic short stature, and primary IGF-I …
PURPOSE OF REVIEW: The Pediatric Endocrine Society recently published new guidelines for the use of human growth hormone (hGH) and human ins …
Who to screen and how to screen for celiac disease.
Singh P, Singh AD, Ahuja V, Makharia GK. Singh P, et al. World J Gastroenterol. 2022 Aug 28;28(32):4493-4507. doi: 10.3748/wjg.v28.i32.4493. World J Gastroenterol. 2022. PMID: 36157923 Free PMC article. Review.
The typical manifestations of CeD such as chronic diarrhea and malabsorption are widely recognized, however, many patients have atypical manifestations like iron deficiency anemia, idiopathic short stature, hypertransaminesemia or infertility, etc. ...In this …
The typical manifestations of CeD such as chronic diarrhea and malabsorption are widely recognized, however, many patients have atypical man …
Etiologies and early diagnosis of short stature and growth failure in children and adolescents.
Rogol AD, Hayden GF. Rogol AD, et al. J Pediatr. 2014 May;164(5 Suppl):S1-14.e6. doi: 10.1016/j.jpeds.2014.02.027. J Pediatr. 2014. PMID: 24731744 Review.
Pathological causes of abnormal growth include many systemic diseases and their treatments, growth hormone deficiency, and a series of genetic syndromes, including Noonan syndrome and Turner syndrome. Children with short stature in whom no specific cause is identifi …
Pathological causes of abnormal growth include many systemic diseases and their treatments, growth hormone deficiency, and a series of genet …
Should Skeletal Maturation Be Manipulated for Extra Height Gain?
Wit JM. Wit JM. Front Endocrinol (Lausanne). 2021 Dec 16;12:812196. doi: 10.3389/fendo.2021.812196. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34975773 Free PMC article. Review.
A similar effect was seen by adding rhGH to GnRHa treatment of children with central precocious puberty with a poor AH prediction and by adding rhGH plus GnRHa to children with congenital adrenal hyperplasia with a poor predicted adult height on conventional treatment with gluco- …
A similar effect was seen by adding rhGH to GnRHa treatment of children with central precocious puberty with a poor AH prediction and by add …
Management of Growth Disorders in Puberty: GH, GnRHa, and Aromatase Inhibitors: A Clinical Review.
Mauras N, Ross J, Mericq V. Mauras N, et al. Endocr Rev. 2023 Jan 12;44(1):1-13. doi: 10.1210/endrev/bnac014. Endocr Rev. 2023. PMID: 35639981 Review.
In growth hormone (GH) deficiency, and in those without identifiable pathologies (idiopathic short stature), the impact of using GH is significantly hindered by the relentless tempo of bone age acceleration caused by sex steroids, limiting time available for …
In growth hormone (GH) deficiency, and in those without identifiable pathologies (idiopathic short stature), the impact …
Basal ganglia calcifications (Fahr's syndrome): related conditions and clinical features.
Donzuso G, Mostile G, Nicoletti A, Zappia M. Donzuso G, et al. Neurol Sci. 2019 Nov;40(11):2251-2263. doi: 10.1007/s10072-019-03998-x. Epub 2019 Jul 2. Neurol Sci. 2019. PMID: 31267306 Free PMC article. Review.
The presence of neuropsychiatric symptoms associated with bilateral basal ganglia calcifications (which could occur in other peculiar brain structures, such as dentate nuclei) identifies a clinical picture defined as Fahr's Disease. This denomination mainly refers to idiopathi
The presence of neuropsychiatric symptoms associated with bilateral basal ganglia calcifications (which could occur in other peculiar brain …
Definition and subcategorization of idiopathic short stature: between consensus and controversy.
Wit JM. Wit JM. Horm Res Paediatr. 2011;76 Suppl 3:3-6. doi: 10.1159/000330134. Epub 2011 Sep 7. Horm Res Paediatr. 2011. PMID: 21912144 Review.
Although various expert and consensus meetings have been held, there remains uncertainty about the definition of idiopathic short stature (ISS) and its subgroups. In this short review, the hypothetical pathophysiology, diagnosis and subcategorization o …
Although various expert and consensus meetings have been held, there remains uncertainty about the definition of idiopathic short
Treatment of children and adolescents with idiopathic short stature.
Ranke MB. Ranke MB. Nat Rev Endocrinol. 2013 Jun;9(6):325-34. doi: 10.1038/nrendo.2013.71. Epub 2013 Apr 23. Nat Rev Endocrinol. 2013. PMID: 23609338 Review.
Idiopathic short stature (ISS) is defined as shortness in childhood without a specific cause. ...Treatment can be considered in an attempt to reduce the psychological burden caused by short stature in childhood and adult life. If counselling alo
Idiopathic short stature (ISS) is defined as shortness in childhood without a specific cause. ...Treatment can be consi
[Idiopathic short stature].
Vlaski J, Katanić D, Privrodski JJ, Kavecan I, Vorguicn I, Obrenović M. Vlaski J, et al. Srp Arh Celok Lek. 2013 Mar-Apr;141(3-4):256-61. doi: 10.2298/sarh1304256v. Srp Arh Celok Lek. 2013. PMID: 23745354 Free article. Review. Serbian.
Idiopathic short stature represents a short stature of unknown cause of heterogeneous etiology, and is characterized by a normal response of growth hormone during stimulation tests (>10 ng/ml or 20 mJ/I), without other disorders, of normal bo
Idiopathic short stature represents a short stature of unknown cause of heterogeneous etiology, and is ch
242 results